Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.65
AMED's Cash-to-Debt is ranked higher than
57% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. AMED: 0.65 )
Ranked among companies with meaningful Cash-to-Debt only.
AMED' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.33 Max: 23.47
Current: 0.65
0
23.47
Equity-to-Asset 0.61
AMED's Equity-to-Asset is ranked higher than
67% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. AMED: 0.61 )
Ranked among companies with meaningful Equity-to-Asset only.
AMED' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.31  Med: 0.55 Max: 1
Current: 0.61
-0.31
1
Debt-to-Equity 0.19
AMED's Debt-to-Equity is ranked higher than
81% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. AMED: 0.19 )
Ranked among companies with meaningful Debt-to-Equity only.
AMED' s Debt-to-Equity Range Over the Past 10 Years
Min: -8.05  Med: 0.26 Max: 15.49
Current: 0.19
-8.05
15.49
Debt-to-EBITDA 1.08
AMED's Debt-to-EBITDA is ranked higher than
78% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. AMED: 1.08 )
Ranked among companies with meaningful Debt-to-EBITDA only.
AMED' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.63  Med: 0.78 Max: 3.17
Current: 1.08
-1.63
3.17
Interest Coverage 10.64
AMED's Interest Coverage is ranked higher than
58% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. AMED: 10.64 )
Ranked among companies with meaningful Interest Coverage only.
AMED' s Interest Coverage Range Over the Past 10 Years
Min: 2.93  Med: 15.44 Max: 115.64
Current: 10.64
2.93
115.64
Piotroski F-Score: 5
Altman Z-Score: 5.41
Beneish M-Score: -2.81
WACC vs ROIC
11.61%
6.31%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % 3.61
AMED's Operating Margin % is ranked lower than
66% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. AMED: 3.61 )
Ranked among companies with meaningful Operating Margin % only.
AMED' s Operating Margin % Range Over the Past 10 Years
Min: -33.08  Med: 3 Max: 15.25
Current: 3.61
-33.08
15.25
Net Margin % 2.70
AMED's Net Margin % is ranked lower than
59% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. AMED: 2.70 )
Ranked among companies with meaningful Net Margin % only.
AMED' s Net Margin % Range Over the Past 10 Years
Min: -26.96  Med: 1.83 Max: 9.33
Current: 2.7
-26.96
9.33
ROE % 8.66
AMED's ROE % is ranked lower than
52% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. AMED: 8.66 )
Ranked among companies with meaningful ROE % only.
AMED' s ROE % Range Over the Past 10 Years
Min: -54.77  Med: 5.95 Max: 20.95
Current: 8.66
-54.77
20.95
ROA % 5.36
AMED's ROA % is ranked higher than
63% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. AMED: 5.36 )
Ranked among companies with meaningful ROA % only.
AMED' s ROA % Range Over the Past 10 Years
Min: -35.44  Med: 3.55 Max: 12.39
Current: 5.36
-35.44
12.39
ROC (Joel Greenblatt) % 142.61
AMED's ROC (Joel Greenblatt) % is ranked higher than
91% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. AMED: 142.61 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMED' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -326.21  Med: 77.02 Max: 233.27
Current: 142.61
-326.21
233.27
3-Year Revenue Growth Rate 2.10
AMED's 3-Year Revenue Growth Rate is ranked lower than
73% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. AMED: 2.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMED' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -26.1  Med: 6.7 Max: 47.3
Current: 2.1
-26.1
47.3
» AMED's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

AMED Guru Trades in Q3 2016

Pioneer Investments Sold Out
Jim Simons 369,401 sh (-41.64%)
Joel Greenblatt 5,938 sh (-88.48%)
» More
Q4 2016

AMED Guru Trades in Q4 2016

Joel Greenblatt Sold Out
Jim Simons 262,300 sh (-28.99%)
» More
Q1 2017

AMED Guru Trades in Q1 2017

Jim Simons 24,800 sh (-90.55%)
» More
Q2 2017

AMED Guru Trades in Q2 2017

Jim Simons 28,618 sh (+15.40%)
Steven Cohen 200,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with AMED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2016-12-31 Sold Out $38.2 - $47.8 $ 50.2718%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:OSTO:ATT, SAU:4004, JSE:LHC, NYSE:AMN, NAS:TVTY, HKSE:01515, SAU:4002, NYSE:THC, SAU:4009, NSE:APOLLOHOSP, ISX:MIKA, SGX:BSL, XTER:RHK, NAS:LPNT, ASX:HSO, JSE:NTC, ASX:PRY, TSE:7716, NAS:LHCG, LSE:SPI » details
Traded in other countries:ADY.Germany,
Headquarter Location:USA
Amedisys Inc is a provider of low-cost home health services to the chronic, co-morbid, aging American population. The Company's operations include servicing patients through its segments home health and hospice.

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.

Ratios

vs
industry
vs
history
PE Ratio 42.97
AMED's PE Ratio is ranked lower than
77% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. AMED: 42.97 )
Ranked among companies with meaningful PE Ratio only.
AMED' s PE Ratio Range Over the Past 10 Years
Min: 4.65  Med: 16.8 Max: 79.39
Current: 42.97
4.65
79.39
Forward PE Ratio 20.96
AMED's Forward PE Ratio is ranked lower than
64% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. AMED: 20.96 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 42.97
AMED's PE Ratio without NRI is ranked lower than
77% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. AMED: 42.97 )
Ranked among companies with meaningful PE Ratio without NRI only.
AMED' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.65  Med: 16.81 Max: 77.36
Current: 42.97
4.65
77.36
Price-to-Owner-Earnings 80.05
AMED's Price-to-Owner-Earnings is ranked lower than
86% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. AMED: 80.05 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AMED' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.12  Med: 20.4 Max: 1705.71
Current: 80.05
4.12
1705.71
PB Ratio 3.46
AMED's PB Ratio is ranked lower than
71% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. AMED: 3.46 )
Ranked among companies with meaningful PB Ratio only.
AMED' s PB Ratio Range Over the Past 10 Years
Min: 0.5  Med: 2.06 Max: 4.5
Current: 3.46
0.5
4.5
PS Ratio 1.16
AMED's PS Ratio is ranked higher than
61% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. AMED: 1.16 )
Ranked among companies with meaningful PS Ratio only.
AMED' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 0.78 Max: 1.9
Current: 1.16
0.19
1.9
Price-to-Free-Cash-Flow 20.05
AMED's Price-to-Free-Cash-Flow is ranked higher than
52% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. AMED: 20.05 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AMED' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.01  Med: 10.43 Max: 58
Current: 20.05
3.01
58
Price-to-Operating-Cash-Flow 17.36
AMED's Price-to-Operating-Cash-Flow is ranked lower than
64% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. AMED: 17.36 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AMED' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.02  Med: 6.45 Max: 30.83
Current: 17.36
2.02
30.83
EV-to-EBIT 26.50
AMED's EV-to-EBIT is ranked lower than
72% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. AMED: 26.50 )
Ranked among companies with meaningful EV-to-EBIT only.
AMED' s EV-to-EBIT Range Over the Past 10 Years
Min: -178.9  Med: 7.4 Max: 2214.4
Current: 26.5
-178.9
2214.4
EV-to-EBITDA 20.50
AMED's EV-to-EBITDA is ranked lower than
71% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. AMED: 20.50 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMED' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.5  Med: 6.8 Max: 65.5
Current: 20.5
-7.5
65.5
EV-to-Revenue 1.17
AMED's EV-to-Revenue is ranked higher than
72% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. AMED: 1.17 )
Ranked among companies with meaningful EV-to-Revenue only.
AMED' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.9 Max: 2.4
Current: 1.17
0.3
2.4
Current Ratio 1.21
AMED's Current Ratio is ranked lower than
58% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. AMED: 1.21 )
Ranked among companies with meaningful Current Ratio only.
AMED' s Current Ratio Range Over the Past 10 Years
Min: 0.33  Med: 1.01 Max: 2.88
Current: 1.21
0.33
2.88
Quick Ratio 1.21
AMED's Quick Ratio is ranked lower than
54% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. AMED: 1.21 )
Ranked among companies with meaningful Quick Ratio only.
AMED' s Quick Ratio Range Over the Past 10 Years
Min: 0.31  Med: 1.01 Max: 2.85
Current: 1.21
0.31
2.85
Days Sales Outstanding 42.84
AMED's Days Sales Outstanding is ranked lower than
54% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. AMED: 42.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.1  Med: 37.17 Max: 54.01
Current: 42.84
30.1
54.01
Days Payable 12.35
AMED's Days Payable is ranked lower than
85% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. AMED: 12.35 )
Ranked among companies with meaningful Days Payable only.
AMED' s Days Payable Range Over the Past 10 Years
Min: 8.33  Med: 12.25 Max: 16.02
Current: 12.35
8.33
16.02

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.10
AMED's 3-Year Average Share Buyback Ratio is ranked higher than
64% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. AMED: -1.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMED' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -47.8  Med: -8.9 Max: 8.1
Current: -1.1
-47.8
8.1

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 12.80
AMED's Price-to-Tangible-Book is ranked lower than
92% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 3.46 vs. AMED: 12.80 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AMED' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.2  Med: 4.51 Max: 120.46
Current: 12.8
0.2
120.46
Price-to-Intrinsic-Value-Projected-FCF 2.23
AMED's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
64% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. AMED: 2.23 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AMED' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.17  Med: 1.45 Max: 86
Current: 2.23
0.17
86
Price-to-Median-PS-Value 1.48
AMED's Price-to-Median-PS-Value is ranked lower than
80% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. AMED: 1.48 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMED' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.12  Med: 0.65 Max: 2.7
Current: 1.48
0.12
2.7
Price-to-Graham-Number 4.95
AMED's Price-to-Graham-Number is ranked lower than
93% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 2.26 vs. AMED: 4.95 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AMED' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.98  Med: 2.64 Max: 11.17
Current: 4.95
0.98
11.17
Earnings Yield (Greenblatt) % 3.77
AMED's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. AMED: 3.77 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMED' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -124.5  Med: 4.5 Max: 32.8
Current: 3.77
-124.5
32.8
Forward Rate of Return (Yacktman) % 35.04
AMED's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. AMED: 35.04 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AMED' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 7  Med: 40.85 Max: 96.7
Current: 35.04
7
96.7

More Statistics

Revenue (TTM) (Mil) $1,477.17
EPS (TTM) $ 1.17
Beta1.45
Short Percentage of Float12.72%
52-Week Range $34.58 - 65.91
Shares Outstanding (Mil)33.86

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,532 1,627
EPS ($) 2.14 2.41
EPS without NRI ($) 2.14 2.41
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}